3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 3
2
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
96
Leukemia
90
Myelodysplastic Syndromes
83
Precursor Cell Lymphoblastic Leukemia-Lymphoma
71
Lymphoma, Non-Hodgkin
62
Lymphoma
60
Multiple Myeloma
53
Hodgkin Disease
48
Leukemia, Lymphocytic, Chronic, B-Cell
46
Myeloproliferative Disorders
41
Leukemia, Myeloid, Chronic-Phase
41
Leukemia, Myeloid, Accelerated Phase
37
Congenital Abnormalities
37
Lymphoma, Large B-Cell, Diffuse
35
Neoplasms, Plasma Cell
34
Lymphoma, Follicular
34
Leukemia, Myelomonocytic, Chronic
34
Burkitt Lymphoma
33
Anemia, Refractory, with Excess of Blasts
32
Lymphoma, Mantle-Cell
31
Lymphoma, B-Cell, Marginal Zone
29
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Lymphoma, Large-Cell, Immunoblastic
28
Blast Crisis
26
Myelodysplastic-Myeloproliferative Diseases
25
Recurrence
24
Primary Myelofibrosis
24
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
24
Hematologic Neoplasms
24
Dendritic Cell Sarcoma, Interdigitating
22
Interventions
Temozolomide
10
Cyclophosphamide
10
Vincristine
9
Etoposide
6
Doxorubicin
6
Irinotecan
5
palbociclib
4
cabozantinib
4
Topotecan
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
X-Rays
3
Sirolimus
3
Phantoms, Imaging
3
Ifosfamide
3
Gemcitabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
ivosidenib
2
irinotecan sucrosofate
2
ganitumab
2
cixutumumab
2
Vemurafenib
2
Trabectedin
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Sarcoma, Ewing
×
Busulfan
×
Clear all
NCT02727387
2022-09-19
EW-2
Italian Sarcoma Group
Phase 2
Completed
155 enrolled